Return to Article Details
QUALITY BY DESIGN DRIVEN FORMULATION DEVELOPMENT AND OPTIMIZATION OF POOR SOLUBLE ANTI-HYPERTENSIVE DRUG FOR IMPROVED SOLUBILITY